Recent advancement in regulatory requirements on hypertension in India as Per CDSCOIN comparison with Australia

Hypertension is a significant health issue in India and Australia, and it is associated with a considerable reduction in adverse cardiovascular disease outcomes. To decrease the prevalence of hypertension by 25% by 2025 and expedite access to treatment services, The India Hypertension Control Initiative (IHCI) was established. To enhance hypertension management in public sector clinics, the IHCI project was introduced in 2018-2019 in 26 districts in five Indian states: Punjab, Madhya Pradesh, Kerala, Maharashtra, and Telangana.
Both India and Australia, face significant public health issues related to hypertension, with 28.1% of adults suffering from the condition. With 28.1% of adults in both India and Australia suffering from hypertension, the two countries face serious public health challenges. India has made great strides toward controlling hypertension and improving regulatory policies. The prevalence in both countries varied significantly between urban and rural areas as well as between specific demographic groups. Men’s awareness, treatment, and control in rural areas were substantially lower than women’s. All of the national studies reported that the prevalence is lower in urban areas when compared to rural areas in Australia, but contrastingly prevalence is higher in urban areas when compared to rural areas. In rural areas, treatment and awareness are especially crucial. With a greater percentage of people suffering from hypertension, it is a serious problem in both countries. This paper examines and compares the regulatory requirements concerning hypertension in the two countries.